Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 19 - Drugs for skeletal disorders
Patents for A61P 19 - Drugs for skeletal disorders (81,981)
12/2003
12/31/2003CN1132612C Medicine for treating rheumatism and cold pain and its utilizing method
12/31/2003CN1132598C 'Yishentongbi' pill for treating hyperosteogeny and its preparing process
12/31/2003CN1132597C The active part of golden pheasant as one Chinese medicine material and its application in preparing medicinal composite
12/31/2003CN1132593C Mixture of white pepper and borneol and its application
12/31/2003CN1132589C Process for preparing plaster to promote circulation of blood and vital energy
12/31/2003CN1132585C Water soluble medical chitose preparation and its preparation
12/31/2003CN1132576C Method for fixing Chinese-medicinal bone-setting paper
12/31/2003CA2495395A1 Method and device for multiplying and differentiating cells in the presence of growth factors and of a biological matrix or of a supporting structure
12/31/2003CA2491210A1 Thiazine and oxazine derivatives as mmp-13 inhibitors for treating arthritis
12/31/2003CA2491209A1 Nitrooxyderivatives of cyclooxygenase-2 inhibitors
12/31/2003CA2490392A1 Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation
12/31/2003CA2490354A1 Drug transport and delivery system
12/31/2003CA2489561A1 Compounds that bind to the interferon-gamma, preparation method thereof and medicaments containing same
12/31/2003CA2487718A1 Arylamine substituted bicyclic heteroaromatic compounds as p38 kinase inhibitors
12/31/2003CA2487541A1 Medicament for the treatment of diseases requiring inhibition or a reduction in the activity of ph value-regulating bicarbonate transporter proteins
12/31/2003CA2487346A1 Cannabinoid receptor agonists
12/31/2003CA2487266A1 Benzimidazole compounds and their use as estrogen agonists/antagonists
12/31/2003CA2445515A1 Transcription factor modulating compounds and methods of use thereof
12/30/2003US6670473 Inhibitors of nitric oxide synthase (nos)
12/30/2003US6670464 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
12/30/2003US6670396 Aspirin-triggered lipid mediators
12/30/2003US6670389 Laulimalide derivatives
12/30/2003US6670365 Substituted imidazo 1,2a}azines as selective inhibitors of cox-2
12/30/2003US6670364 Antagonists of MCP-1 function and methods of use thereof
12/30/2003US6670357 Antiinflammatory agents
12/30/2003US6670346 Treatment and/or inhibition of the development of osteoporosis, breast cancer, hypercholesterolemia, hyperlipidemia or atherosclerosis in susceptible warm-blooded animals including humans, administering selective estrogen
12/30/2003US6669966 Topically applying oxides of bismuth, cobalt, copper, iron, manganese or praseodymium, as ointments or on bandages to improve neovascularization of injuries or skin disorders
12/30/2003US6669623 One-shelled or multi-shelled nanoscalar particles composed of a core containing iron oxide and of an inner shell with groups capable of forming cationic groups which generates heat when alternating electromagnetic field applied
12/30/2003US6668527 Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
12/30/2003CA2380690C Human osteoclast-derived cathepsin
12/30/2003CA2175971C Stable liquid composition containing urate oxidase and lyophilized composition for its preparation
12/30/2003CA2158331C Injection vessel and solution-enclosed injection vessel in use thereof
12/30/2003CA2052884C Angiotensin 11 antagonists in the treatment of hyperuricemia
12/29/2003WO2004002469A1 Isoflavone concentrate and method for production thereof
12/29/2003CA2448513A1 Isoflavone concentrates, as well as methods for their production
12/25/2003US20030237101 Stem cell factor; modulation of gene expression
12/25/2003US20030236574 Composition and device for in vivo cartilagerepair
12/25/2003US20030236412 Cyclic AMP-specific phosphodiesterase inhibitors
12/25/2003US20030236389 Proteins, polynucleotides encoding them and methods of using the same
12/25/2003US20030236303 Therapeutic compositions and methods of use
12/25/2003US20030236263 Chemical compounds
12/25/2003US20030236258 Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents
12/25/2003US20030236244 Antiallergens; autoimmune diseases; antiproliferative agents; controlling signal transduction
12/25/2003US20030236230 Comprises 4-substituted piperidine ring linked to a substituted or unsubstituted hydrocarbyl ring; for controlling weight gain in a human or higher mammal
12/25/2003US20030236193 Methods of treatment using specific binding agents of human angiopoietin-2
12/25/2003US20030236182 Therapeutic and diagnostic methods for ulcerative colitis and associated disorders
12/25/2003US20030235888 Therapy for bone defects
12/25/2003US20030235620 Animal extracts used as lipoxygenase inhibitors, antidiabetic, antiinflammatory, antiarthritic or antidiabetic agents; molluscs
12/25/2003US20030235588 Thioredoxin (TRX); administering histone deacetylase inhibitors such as trichostatin A; for treating inflammation
12/25/2003US20030235585 Methods of treating disorders in which TFN alpha activity is detrimental via biweekly, subcutaneous administration of human antibodies, preferably recombinant human antibodies, that specifically bind to human tumor necrosis factor alpha
12/25/2003US20030235584 Method for preparing anti-MIF antibodies
12/25/2003US20030235558 Contacting a compound with a sample containing p62 and ubiquitin, determining level of p62/ubiquitin binding under normal conditions and in the presence of the compound and comparing the two levels
12/24/2003WO2003106660A2 Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier
12/24/2003WO2003106506A1 Low molecular weight oversulfated polysaccharide
12/24/2003WO2003106505A1 Process for the manufacture of n-acyl-(epi)k5-amine-o-sulfate-derivatives and products thus obtained
12/24/2003WO2003106504A1 Epimerized derivatives of k5 polysaccharide with a very high degree of sulfation
12/24/2003WO2003106455A1 Azole methylidene cyanide derivatives and their use as protein kinase modulators
12/24/2003WO2003106431A2 Novel hexahydro-pyridazine-3-carbocylic acid hydrazide or hydrazone derivatives, combinatorial libraries containing same, use thereof as medicines, pharmaceutical compositions containing same and methods for preparing same
12/24/2003WO2003106425A2 Phenyl- and pyridyl-diazaheterocycles having a tnf-modulating activity
12/24/2003WO2003106411A1 24-sulfoximine vitamin d3 compounds
12/24/2003WO2003106401A1 N-bridged selective androgen receptor modulators and methods of use thereof
12/24/2003WO2003106381A2 Human adam-10 inhibitors
12/24/2003WO2003105893A2 Probiotic therapies
12/24/2003WO2003105858A1 Hyaluronic acid-associated superoxide dismutase mimics and their use in the treatment of joint pain
12/24/2003WO2003105834A1 Bazedoxifene treatment regimens
12/24/2003WO2003105829A1 A formulation of traditional chinese medicine for preventing and treating osteoporosis
12/24/2003WO2003105800A2 Film-shaped mucoadhesive administration form for administering cannabis active ingredients
12/24/2003WO2003105776A2 ANALOGUES OF LIPID MEDIATORS DERIVED FROM OMEGA-3 PUFAs AND METHODS OF USE
12/24/2003WO2003105771A2 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylates and 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)pyrrolidine-3-carboxylates as edg receptor agonists
12/24/2003WO2003105752A2 Methods and compositions for stimulating bone growth using nitric oxide releasing bisphosphonate conjugates (no-bisphosphonate)
12/24/2003WO2003086396A9 Phosphodiesterase iv inhibitor containing pyridylacrylamide derivative
12/24/2003WO2003084940B1 Thiazolidine-4-carbonitriles and analogues and their use as dipeptidyl-peptidas inhibitors
12/24/2003WO2003083080A3 Mixed- cell gene therapy
12/24/2003WO2003082807A3 Amino acids with affinity for the alpha-2-delta-protein
12/24/2003WO2003070914A3 RNA INTERFERENCE MEDIATED INHIBITION OF FOS GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
12/24/2003WO2003068224A3 Use of inhibitors of the sodium-dependent chloride-bicarbonate-exchanger for treating thrombotic and inflammatory diseases
12/24/2003WO2003066840A3 Pluripotent embryonic-like stem cells derived from teeth and uses thereof
12/24/2003WO2003066806A3 Therapeutic use of aziridino compounds
12/24/2003WO2003066048A3 Use of 15-lipoxygenase inhibitors for treating and preventing bone loss
12/24/2003WO2003064685A3 Genetic polymorphisms in the preprotachykinin gene
12/24/2003WO2003063800A3 8-heteroaryl xanthine adenosine a2b receptor antagonists
12/24/2003WO2003062236A8 2-(PYRIDIN-2-YLAMINO)-PYRIDO[2,3d]PYRIMIDIN-7-ONES
12/24/2003WO2003053361A3 PYRROLOPYRIMIDINE A2b SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE
12/24/2003WO2003050272A3 Bone development model
12/24/2003WO2003048148A9 Statin-like compounds
12/24/2003WO2003047611A3 Ptp10d, tec and edtp involved in triglycerid-metabolism
12/24/2003WO2003038095A3 Isolated peptide of the hepatocyte growth factor and its variants, preparation method and therapeutic use as anti-angiogenic agents
12/24/2003WO2003037362A3 Mnk kinase homologous proteins involved in the regulation of energy homeostasis and organelle metabolism
12/24/2003WO2003035137A3 Method and apparatus for dispensing inhalator medicament
12/24/2003WO2003011230A3 Modified reoviral therapy
12/24/2003WO2003006491A3 Peptide-based compounds for targeting intergin receptors
12/24/2003WO2002102997A3 Isolated homozygous stem cells differentiated cells derived therefrom and materials and methods for making and using same
12/24/2003WO2002092764A3 Transgenic animal model of bone mass modulation
12/24/2003WO2002087505A3 3-structure of a whole integrin $g(a)v$g(b)3 extracellular region and uses therefor
12/24/2003WO2002074955A3 Oligonucleotides for regulating the gene coding for tnf$g(a) and/or genes controlled thereby and use thereof
12/24/2003WO2002046147A3 Perturbed membrane-binding compounds
12/24/2003WO2002034204A8 Calcilytic compounds
12/24/2003WO2002018540A3 Pyridine derivatives useful as cd40:cd154 binding interruptor compounds and use thereof to treat immunological complications
12/24/2003CN1462755A Method for distilling active protein liquid of scorpion
12/24/2003CN1462632A Usage of internal use and external used medicine made from fleur-de-lis and its preparation method
1 ... 541 542 543 544 545 546 547 548 549 550 551 552 553 554 555 556 557 558 559 560 561 ... 820